Phathom pharmaceuticals to present at the guggenheim securities smid cap biotech conference

Florham park, n.j., jan. 29, 2025 (globe newswire) -- phathom pharmaceuticals, inc. (nasdaq: phat), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (gi) diseases, announced today that members of the management team will participate in a fireside chat at the guggenheim securities smid cap biotech conference on thursday, february 6, 2025, at 10:00 am et.
SMID Ratings Summary
SMID Quant Ranking